Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease.

Williams, C J M

Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease. [electronic resource] - Alimentary pharmacology & therapeutics Mar 2014 - 447-58 p. digital

Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review

1365-2036

10.1111/apt.12624 doi


Adalimumab
Anti-Inflammatory Agents--adverse effects
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized--adverse effects
Certolizumab Pegol
Colitis, Ulcerative--drug therapy
Crohn Disease--drug therapy
Humans
Immunoglobulin Fab Fragments--adverse effects
Infliximab
Neoplasms--chemically induced
Polyethylene Glycols--adverse effects
Randomized Controlled Trials as Topic
Risk
Tumor Necrosis Factor-alpha--antagonists & inhibitors